GGrantIndex
Sort

39,280 grants matching leukemia

Phase 2 Study of Interferon-Gamma and Donor Lymphocyte Infusion for the Treatment of Relapsed Myeloid Malignancies after Allogeneic Stem Cell Transplantation

$882,247
Sawa Ito · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · FD

Sequencing and Integrated Analysis of AML Genomes

$882,105
Richard K. Wilson · Washington University · P01 · FY2015 · CA

An allosteric inhibitor of ZAP-70 as a novel therapeutic for autoimmune disease

$881,498
Arthur Weiss · University Of California, San Francisco · RC2 · FY2010 · AR

Novel DNA Repair Inhibitors for Cancer Therapy

$880,502
Peter M Glazer · Yale University · R35 · FY2019 · CA

Clinical Development of Novel Drugs for Children with Refractory Cancers

$880,382
Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA

Mechanisms of non-classical multidrug resistance in cancer

$880,230
Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

IL-2 Family Cytokines and their Receptors-- Molecular Regulation via STATs

$880,077
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL

Adoptive T cell Therapy for Pediatric Leukemia

$879,682
Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

CANCER AND INFLAMMATION GENETICS

$879,352
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

CANCER AND INFLAMMATION: FUNCTION AND THERAPY

$879,352
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Occupational and Environmental Determinants of Cancer among Women and Minorities

$879,344
Wong Chow · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA

Role of autoreactivity in pathogenesis of chronic graft versus host disease

$879,263
Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2024 · HL

Role of autoreactivity in pathogenesis of chronic graft versus host disease

$879,263
Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2025 · HL

Preventing GVHD by inhibition of alloantigen presentation in the gut

$878,801
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2025 · HL

PEDIATRIC CHTN--AIDS CANCER RESEARCH

$877,793
Research Inst Nationwide Children'S Hosp · U01 · FY2005 · CA

Role of 11q23 Chromosome Abnormalities in the Causation of Acute Leukemia

$877,670
Carlo M Croce · Ohio State University · P01 · FY2013 · CA

GrowthDifferentiation Factors in Organogenesis

$877,374
Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Mechanisms of Cellular Transformation by HTLV-1

$876,847
Kuan-Teh Jeang · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Lymphomas And Retroviral Pathogenesis

$876,350
Herbert Morse · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Targeted Therapies for Childhood Acute Lymphoblastic Leukemia

$876,194
Stephen Patrick Hunger · National Childhood Cancer Foundation · RC2 · FY2010 · CA

Development of Novel Therapies for Acute Lymphoblastic Leukemia

$876,050
Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Lymphomas And Retroviral Pathogenesis

$876,014
Herbert C Morse · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors

$875,950
Smita Bhatia · University Of Alabama At Birmingham · R35 · FY2022 · CA

Severe Chronic Neutropenia International Registry

$875,729
David Chandler Dale · University Of Washington · R24 · FY2012 · AI

Molecular strategies for early detection and targeting of cancer

$875,675
Tannishtha Reya · University Of California, San Diego · R35 · FY2019 · CA